Using race as a social construct when looking at differences in racial associations between non­alcoholic fatty liver disease and type 2 diabetes. Reply to Rollin FG, Washington C, Fluker S-A [letter].

Hatano, Yu; VanWagner, Lisa B; Carnethon, Mercedes R; Bancks, Michael P; Carson, April P; Lloyd-Jones, Donald M; Østbye, Truls; Viera, Anthony J; Yano, Yuichiro

Using race as a social construct when looking at differences in racial associations between nonalcoholic fatty liver disease and type 2 diabetes. Reply to Rollin FG, Washington C, Fluker S-A [letter].

Hatano, Yu; VanWagner, Lisa B; Carnethon, Mercedes R; Bancks, Michael P; Carson, April P; Lloyd-Jones, Donald M; Østbye, Truls; Viera, Anthony J; Yano, Yuichiro.

Afiliação

Hatano Y; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan. yu.hatano@cira.kyoto-u.ac.jp.
VanWagner LB; Division of Digestive Liver Diseases, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Carnethon MR; Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Bancks MP; Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Carson AP; Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
Lloyd-Jones DM; Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Østbye T; Department of Family Medicine and Community Health, Duke University, Durham, NC, USA.
Viera AJ; Department of Family Medicine and Community Health, Duke University, Durham, NC, USA.
Yano Y; Department of Advanced Epidemiology, Noncommunicable Disease (NCD) Epidemiology Research Center, Shiga University of Medical Science, Otsu, Japan.